Bioasis Technologies Inc. (BIOAF)

OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0002 (-99.50%)
At close: Nov 10, 2025
Market Cap79.00 -100.0%
Revenue (ttm)199.01K +614.1%
Net Income-2.12M
EPS-0.03
Shares Out79.41M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19,541
Average Volume14,766
Open0.0000
Previous Close0.0002
Day's Range0.0000 - 0.0000
52-Week Range0.0000 - 0.0006
Beta86.99
RSI42.33
Earnings Daten/a

About Bioasis Technologies

Bioasis Technologies Inc. operates as a biopharmaceutical company. The company utilizes its proprietary xB3 platform to deliver therapeutics across the blood-brain barrier and treat central nervous system disorders in areas of high unmet medical need. Bioasis Technologies Inc. is based in New Haven, Connecticut. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol BIOAF
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements